




























Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Pawley, A. D., Chowdhury, F. A., Tangwiriyasakul, C., Ceronie, B., Elwes, R. D. C., Nashef, L., & Richardson, M.
P. (2017). Cortical excitability correlates with seizure control and epilepsy duration in chronic epilepsy. Annals of
clinical and translational neurology, 4(2), 87-97. DOI: 10.1002/acn3.383
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
RESEARCH ARTICLE
Cortical excitability correlates with seizure control and
epilepsy duration in chronic epilepsy
Adam D. Pawley1, Fahmida A. Chowdhury1, Chayanin Tangwiriyasakul1, Bryan Ceronie1,
Robert D. C. Elwes2, Lina Nashef2 & Mark. P. Richardson1
1Department of Basic and Clinical Neuroscience, King’s College London, London, United Kingdom
2Centre for Epilepsy, King’s College Hospital, London, United Kingdom
Correspondence
Mark Richardson, Department of Basic and
Clinical Neuroscience, Institute of Psychiatry,
Psychology and Neuroscience, De Crespigny
Park, London SE8 8AF. Tel: +44 (0)208 7848
5429; Fax: +44 (0)203 228 2116; E-mail:
mark.richardson@kcl.ac.uk
Funding Information
The study was supported by a PhD
studentship from Epilepsy Action held by
A.P.; a UK Medical Research Council (MRC)
Clinical Research Training Fellowship held by
F.A.C.; and a Programme Grant from MRC
held by M.P.R. (MR/K013998/1). M.P.R. is
supported in part by the National Institute for
Health Research (NIHR) Biomedical Research
Centre in Mental Health at the South London
and Maudsley NHS Foundation Trust and by
the UK Engineering and Physical Sciences
Research Council (EPSRC) Centre for
Predictive Modelling in Healthcare at the
University of Exeter (EP/N014391/1).
Received: 25 August 2016; Revised: 6
November 2016; Accepted: 8 November
2016
Annals of Clinical and Translational
Neurology 2017; 4(2): 87–97
doi: 10.1002/acn3.383
Abstract
Objective: Cortical excitability differs between treatment responders and non-
responders in new-onset epilepsy. Moreover, during the first 3 years of epilepsy,
cortical excitability becomes more abnormal in nonresponders but normalizes
in responders. Here, we study chronic active epilepsy, to examine whether cor-
tical excitability continues to evolve over time, in association with epilepsy
duration and treatment response. Methods: We studied 28 normal subjects, 28
patients with moderately controlled epilepsy (≤4 seizures per year) and 40
patients with poorly controlled epilepsy (≥20 or more seizures per year). Rest-
ing motor threshold (RMT), active motor threshold (AMT), short-interval
intracortical inhibition (SICI), intracortical facilitation (ICF) and cortical silent
period (CSP) were measured, using transcranial magnetic stimulation (TMS).
Disease and treatment covariates were collected (age at onset of epilepsy, epi-
lepsy duration, number of drugs prescribed, total drug load, sodium channel
drug load). Results: RMT and AMT were higher in patients than in normal
subjects; RMT and AMT were higher in poorly controlled than moderately con-
trolled patients. ICF at 12 msec and 15 msec were lower in poorly controlled
patients than in normal subjects. Long-interval intracortical inhibition (LICI) at
50 msec was higher in poorly controlled compared to moderately controlled
patients. These differences were not explained by antiepileptic drug (AED)
treatment or duration of epilepsy. RMT and AMT increased with duration in
the poorly controlled group, but did not increase with duration in the moder-
ately controlled group. Interpretation: Cortical excitability differs markedly
between moderately controlled and poorly controlled patients with chronic epi-
lepsy, not explained by disease or treatment variables. Moreover, the evolution
of cortical excitability over time differs, becoming more abnormal in the poorly
controlled group.
Introduction
Epilepsy is a condition in which the inhibition–excitation
balance in brain networks is altered in such a way that
seizures can periodically emerge. Given that epilepsy may
reflect an imbalance between excitation and inhibition,
Transcranial Magnetic Stimulation (TMS) has been used
extensively to measure cortical excitability in human epi-
lepsy, both to investigate disease phenomena and to
investigate the mechanism of action of antiepileptic drugs
(AEDs).1 TMS has identified differences in cortical
excitability between patients with epilepsy taking AEDs
and healthy controls in both generalized2–4 and focal epi-
lepsy5,6; however, findings have been inconsistent. The
variability of findings between studies is likely to reflect
differences in AED treatment7, differences in seizure fre-
quency8 and differences in epilepsy duration.9
One group of investigators used TMS to study a large
set of patients with drug-na€ıve new-onset epilepsy8 and
followed them for 3 years.9 The key finding of this
important study was that patients with new-onset epi-
lepsy showed increased cortical excitability measured
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with TMS, which is in accord with a simple notion that
epilepsy is caused by ‘hyperexcitable’ brain networks.
Moreover, patients who became seizure-free on AED
treatment showed a change in TMS measurements, los-
ing the ‘hyperexcitable’ profile and becoming normal;
whereas patients who did not respond to AEDs
remained ‘hyperexcitable’ for up to 3 years, despite
being on AED treatment. This work suggests that
patients with longstanding uncontrolled epilepsy with
duration longer than 3 years may continue to show a
‘hyperexcitable’ profile, despite being on AEDs. However,
this is substantially out of keeping with existing studies
which show that patients with longstanding uncontrolled
epilepsy have reduced cortical excitability compared to
normal subjects, evidenced for example by increased
motor threshold.4,6,10,11
In the current study, we use TMS to investigate a
group of patients with longstanding uncontrolled epi-
lepsy. We test the hypothesis that patients with longstand-
ing uncontrolled epilepsy have a ‘hyperexcitable’ profile
of TMS measurements. We carefully examine the influ-
ence of multiple other factors, particularly seizure fre-
quency, AED treatment load, and epilepsy duration.
Methods
Subjects
Patients were recruited from the epilepsy clinics at King’s
College Hospital, London UK, and were a consecutive
series who fitted the inclusion and exclusion criteria and
were able to participate. Adult patients over 18 years of
age with epilepsy currently treated with AEDs were
recruited into two groups: patients with between 1 and 4
seizures in the last 12 months comprised the ‘moderately
controlled’ group; patients with 20 or more seizures in
the previous 12 months comprised the ‘poorly-controlled’
group. We chose these ranges of seizure frequency for the
following reasons. A prior study found approximately half
of patients with epilepsy had zero seizures in the previous
year, approximately a quarter had 1–9 seizures in the pre-
vious year, and the rest had 10 or more12, regarding these
latter two groups as moderately controlled active epilepsy
and poorly controlled active epilepsy. We were especially
concerned to minimize misclassification of subjects into
moderately controlled and poorly controlled groups
resulting from inaccuracy of self-reporting of seizures13,
therefore we purposefully created a wide separation
between our groups by setting 4 as the upper limit for
the moderately controlled group and 20 as the lower limit
for the poorly controlled group. Patients were excluded if
they had contraindications to TMS procedures, any other
neurological or psychiatric condition, nonepileptic
seizures, were unable to give consent, could not cooperate
with TMS procedures, or did not keep a seizure diary.
The study was approved by Bromley Research Ethics
Committee (reference 12/LO/0230). Written informed
consent was obtained in all cases.
Normal control data were available from a previously
published study collected by members of the same team
of investigators, using the same equipment and labora-
tory14; 28 subjects had suitable data.
Acquisition of TMS data
Data were collected on a single occasion with subjects
relaxed and alert. Electrodes were applied to the first dor-
sal interosseous bilaterally. The optimal coil position on
the scalp for obtaining motor evoked potentials (MEPs)
from the contralateral first dorsal interosseous was estab-
lished.15 Resting motor threshold (RMT) and active
motor threshold (AMT) were measured.15 AMT was
recorded while subjects squeezed a manometer at 20% of
each individual’s maximum contraction force. Short-
interval intracortical inhibition (SICI) and intracortical
facilitation (ICF) were measured, using conditioning-test
stimuli pairs given in a random order at each interstimu-
lus interval (ISI; SICI at ISIs 2 msec and 3 msec, ICF at
12 msec and 15 msec). The conditioning stimulus was
80% of AMT and the suprathreshold stimulus 120%
RMT. Long-interval intracortical inhibition (LICI) was
measured using two suprathreshold pulses at 120% of
RMT, at ISIs of 50 msec, 150 msec, 200 msec and
250 msec. Finally, cortical silent period (CSP) was mea-
sured with single pulses applied at 120% of AMT, with
subjects squeezing a manometer at 20% of their maxi-
mum voluntary contraction.
The calculation of SICI and LICI utilized custom
scripts to measure the amplitudes of conditioned MEPs
and to express SICI, ICF and LICI at each ISI as a per-
centage of the amplitude of the unconditioned MEPs
(conditioned mean/unconditioned mean). To measure
CSP, to minimize observer bias, we measured from the
TMS stimulus artifact to the end of the CSP as indicated
using the cumulative sum approach.16
Potentially confounding factors and
covariates
We collected the following clinical data which we
assumed may associate with TMS measurements and/or
associate with the assignment of the patients to moder-
ately controlled and poorly controlled groups: age at time
of TMS study, sex, age at onset of epilepsy, duration of
epilepsy, epilepsy syndrome, onset lateralization in focal
cases, AEDs currently prescribed, and doses.
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Due to the impact of AEDs on TMS parameters7,17, we
particularly sought to take account of AED effects on
TMS measurements. We adopted three measures of AED
effects: number of AEDs currently prescribed; total drug
load; and sodium-channel drug load. Drug load for an
individual drug was determined as the ratio of prescribed
daily dose to defined daily dose. Defined daily dose is
determined by the WHO Collaborating Centre for Drug
Statistics Methodology18, defined as the assumed average
maintenance dose per day for a drug used for its main
indication in adults. Data for defined daily dose were
accessed at http://www.whocc.no/atc_ddd_index/. Total
drug load was calculated for each patient by summing the
drug load for each AED. Separately, we calculated the
sodium channel load for each patient. AEDs included
were phenytoin, carbamazepine, lamotrigine, oxcar-
bazepine, zonisamide, rufinamide, lacosamide, and eslicar-
abazepine. Other medications such as topiramate and
valproate whose probable or partial mechanism of action
may include blockade of sodium channels were not
included.19 The sodium channel drug load was calculated
for each patient by summing the drug load for each
sodium channel blocking AED.
Statistical analysis
We conducted a small number of primary analyses fol-
lowed by a series of exploratory secondary analyses. All
statistical tests were conducted using SPSS version 21
(IBM). All TMS measures showed strong correlations
between hemispheres across subjects and no significant
differences between hemispheres within subjects; there-
fore, we averaged data from left and right for each sub-
ject. This reduced the number of nonindependent
comparisons being made. For some exploratory secondary
analyses, we split ipsilateral and contralateral hemispheres
in the focal epilepsy group.
We assumed RMT and AMT would be highly corre-
lated within subjects, therefore we included both mea-
sures in a single ANOVA with the within-subjects factor
“RMT-AMT” (2 levels), and the between-subjects factor
“group” (3 levels: moderately controlled, poorly con-
trolled, normal subjects). We tested the hypothesis that
the groups differed. Any significant effects were explored
using T-tests to examine for differences between pairs of
groups, correcting for unequal variances, and correcting
for 6 comparisons (3 between group comparisons for
each of 2 measures, Bonferroni-corrected P-value 0.05/
6 = 0.0083). Significant ANOVA effects were also exam-
ined by constructing a series of further ANOVAs compar-
ing moderately controlled versus poorly controlled
patients, each ANOVA including one of several poten-
tially confounding covariates (age, age of onset of
epilepsy, duration of epilepsy, number of AEDs currently
prescribed, total drug load, sodium channel drug load).
Additionally, an ANOVA was constructed with the factor
focal/generalized epilepsy.
Similarly, we assumed SICI and ICF would be corre-
lated, therefore undertook an exactly analogous approach
by including all measures in an ANOVA with the within-
subjects factor “ISI” (4 levels: 2 msec, 3 msec, 12 msec,
15 msec), and the between-subjects factor “group” (3
levels: moderately controlled, poorly controlled, normal
subjects). We tested the hypothesis that the groups dif-
fered. As with motor threshold, we further explored any
significant effects using T-tests, correcting for 12 compar-
isons (Bonferroni-corrected P-value threshold 0.05/
12 = 0.0042). Significant ANOVA effects were also exam-
ined by constructing a series of further ANOVAs compar-
ing moderately controlled versus poorly controlled
patients, each ANOVA including one of several poten-
tially confounding covariates, as for motor threshold.
LICI data were examined exactly as SICI/ICF data. CSP
data were examined using a univariate ANOVA but
otherwise with an identical scheme (Bonferroni correcting
three between-group T-test P-values using a P-value
threshold of 0.05/3 = 0.0167).
The final primary analysis was a series of regression
analyses, to examine the correlation between RMT, AMT,
SICI, ICF, LICI, CSP, and the various covariates (age, age
of onset of epilepsy, duration of epilepsy, number of
AEDs currently prescribed, total drug load, sodium chan-
nel drug load), to test the hypothesis that TMS measures
vary in association with these disease and treatment vari-
ables.
Where primary analyses had found effects of interest in
the entire patient group, in subsequent secondary analyses
we explored whether these effects were present in the gen-
eralized and focal groups separately. We also undertook
detailed exploration of interactions between factors and
covariates of greatest interest in the primary analyses.
Results
96 subjects were included: 28 normal subjects, 28 subjects
with moderately controlled epilepsy and 40 patients with
poorly controlled epilepsy (see Table 1 for demographics
and clinical features). There were 19 patients with IGE/
GGE (8 Juvenile Myoclonic Epilepsy (JME), 5 generalized
tonic clinic seizures only, 5 Juvenile Absence Epilepsy, 1
Childhood Absence Epilepsy). There were 49 patients with
focal-onset epilepsy (2 bilateral seizure onset, 26 left
onset, 16 right, 5 uncertain lateralization; 9 frontal lobe
onset, 36 temporal lobe, 1 parietal lobe, 3 had uncertain
lobar onset). Using chi-squared to test for a difference in
proportions of moderately controlled versus poorly
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controlled patients with each epilepsy syndrome, there
were no differences in the proportions with different
lobar localizations in focal epilepsy or different IGE syn-
dromes. The patient groups were well-matched except for
duration of epilepsy and number of AEDs currently pre-
scribed. Twenty-four patients were taking carbamazepine
(9 moderately controlled, 15 poorly controlled), 21 were
taking lamotrigine (12, 9), 15 levetiracetam (4, 11), 10
sodium valproate (5, 5), 6 topiramate (2, 4), 3 zonisamide
(2, 1), 3 lacosamide (1, 2), 2 phenytoin (0, 2), 1 tiagabine
(0, 1), 1 gabapentin (0, 1) and 1 rufinamide (0, 1). Using
chi-squared to test for a difference in proportions of
moderately controlled versus poorly controlled patients
taking each AED, there were no significant differences
between these groups. Eighteen moderately controlled and
28 poorly controlled patients had epileptiform EEG
abnormalities on routine EEG, and 7 in each group had
an epileptogenic abnormality on MRI; using chi-squared
to test for a difference in proportions between groups,
neither of these was significantly different.
Not all subjects underwent all TMS measures, mostly
because of minor discomfort during TMS. The number of
normal subjects, moderately controlled and poorly con-
trolled patients undergoing each measure was as follows:
motor thresholds n = 28, n = 28, n = 40 respectively;
SICI/ICF n = 28, n = 24, n = 24; LICI n = 28, n = 24,
n = 21; CSP n = 27, n = 28, n = 39.
Motor thresholds: primary analysis
Motor thresholds differed significantly between moder-
ately controlled patients, poorly controlled patients, and
normal subjects (F = 26.74, P < 0.001, Fig. 1). Normal
subjects had lower motor thresholds than either patient
group (RMT vs. moderately controlled T = 2.819,
P = 0.007; AMT vs. moderately controlled T = 4.726,
P < 0.001; RMT vs. poorly controlled T = 6.528,
P < 0.001; AMT vs. poorly controlled T = 7.651,
P < 0.001). Poorly controlled patients had higher motor
thresholds than moderately controlled patients (RMT
T = 4.193, P < 0.001, AMT T = 3.884, P < 0.001). All
these P-values remained significant after Bonferroni cor-
rection. Further ANOVAs comparing moderately con-
trolled and poorly controlled groups were carried out,
including potentially confounding covariates as described
in the Methods. Differences between patient groups
remained extremely significant despite these additional
covariates or factors (P = 0.001 or less in all cases), and
there was no main effect or interaction involving the fac-
tor focal/generalized epilepsy. In particular, differences in
motor thresholds between moderately controlled and
poorly controlled groups were not explained by any AED
treatment variables.
We explored the correlations between motor thresholds
and several covariates as described in the Methods. Both
RMT and AMT were correlated with duration of epilepsy
(r = 0.326, P = 0.007; r = 0.309, P = 0.011 respectively)
but no other correlations were significant (all r < 0.2 and
P > 0.1). The correlation between RMT or AMT and
duration of epilepsy remained significant in a series of
regression analyses, each analysis including one of several
additional independent variables: age, age of onset, num-
ber of drugs currently taken, total drug load, and sodium
channel drug load; notably, none of the other variables
had a significant effect in these regression analyses.
Motor thresholds: secondary analysis
We examined the generalized and focal epilepsy groups
separately using a threshold of P = 0.05 uncorrected

















Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Well controlled Generalized 10 5F 34.20 11.18 14.80 6.46 20.40 13.83 1.40 0.70 1.40 1.27 0.67 0.98
Focal 18 11F 37.39 14.28 24.18 15.30 12.94 7.33 1.33 0.59 1.43 1.08 1.20 0.79
Combined 28 16F 36.25 13.14 20.70 13.41 15.70 10.62 1.36 0.62 1.42 1.12 1.01 0.88
Poorly controlled Generalized 9 7F 34.78 15.05 13.33 7.57 21.44 17.88 1.78 0.67 1.62 0.89 0.69 0.63
Focal 31 14F 42.68 14.28 18.48 14.52 23.58 12.44 1.61 0.72 1.54 0.74 0.98 0.63
Combined 40 21F 40.90 14.64 17.33 13.37 23.10 13.62 1.65 0.70 1.56 0.77 0.91 0.63
Normal subjects 28 15F 33.46 8.25
t P t P t P t P t P t P
Well controlled versus poorly
controlled
1.137 0.176 1.013 0.315 2.492 0.015 1.815 0.074 0.566 0.574 0.469 0.641
SD, standard deviation, F, female, t, value of t-statistic, P, P-value.
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(Fig. 1); therefore, these comparisons should be regarded
as exploratory trends. In the generalized group, motor
thresholds differed between moderately controlled and
poorly controlled (F = 6.96, P = 0.017). Moderately con-
trolled patients had lower motor thresholds than poorly
controlled (RMT T = 2.427, P = 0.032, AMT T = 2.521,
P = 0.030). In the focal group, motor thresholds differed
significantly between moderately controlled and poorly
controlled (F = 4.69, P = 0.036). Furthermore, motor
thresholds differed between ipsilateral and contralateral
hemispheres (F = 4.281, P = 0.045). In the contralateral
hemisphere, motor thresholds were higher in the poorly
controlled group than in the moderately controlled group
(RMT: T = 3.100, P = 0.004; AMT: T = 2.827, P = 0.008)
but there were no differences in the ipsilateral hemi-
sphere.
Subsequently, we explored whether the correlation
between motor threshold and duration of epilepsy was
similar in moderately controlled and poorly controlled
patients. This revealed no correlation in the moderately
controlled group (correlation between duration and RMT
r = 0.058, AMT r = 0.075), whereas both RMT and AMT
increased with duration in the poorly controlled group
(RMT r = 0.297, AMT r = 0.268). To explore these data
further, we assigned each subject to one of four bins
according to epilepsy duration. In each duration bin, we
compared RMT and AMT between moderately controlled
patients and poorly controlled patients, and compared
each of these groups with normal subjects (Fig. 2); hence
there were 24 nonindependent comparisons, therefore we
used 0.05/24 = 0.00208 as the P-value threshold. Poorly
controlled patients had higher RMT in the 10–19 years,
20–29 years and 30+ years duration groups than normal
subjects (T = 4.194, P = 0.001; T = 5.19, P < 0.001;
T = 5.122, P < 0.001 respectively). Poorly controlled
patients also had higher AMT in the 20–29 years and 30+
years duration groups than normal subjects (T = 5.916,
P < 0.001; T = 5.519, P < 0.001 respectively). Moderately
controlled patients did not differ from normal subjects in
any duration group. Comparing moderately controlled
and poorly controlled patients, at P = 0.05 uncorrected,
poorly controlled patients had higher RMT in the 20-
29 years and 30+ years duration groups, and higher AMT
in the 30+ years duration group, than moderately con-
trolled patients (T = 3.702, P = 0.002; T = 2.609,
P = 0.027; T = 3.07, P = 0.009).
SICI and ICF: primary analysis
Comparing SICI and ICF between moderately controlled
patients, poorly controlled patients, and normal subjects,
although there was no main effect of group, there was a sig-
nificant interaction between group and ISI (F = 3.186,
P = 0.006, Fig. 3). Poorly controlled patients had less ICF
than normal subjects (12 msec ISI T = 3.516, P = 0.001;
15 msec ISI T = 4.497, P < 0.001); these P-values remained
significant after correction for 12 nonindependent compar-
isons. There was a trend that normal subjects had more
inhibition at 2 msec ISI than either moderately controlled
or poorly controlled patients, significant at P < 0.05 but
not surviving correction for multiple comparisons (normals
vs. moderately controlled T = 2.480, P = 0.017; normals vs.
poorly controlled T = 2.531, P = 0.015).
We explored the correlations between measures of SICI
and ICF and several covariates as described in the Meth-
ods. ICF at 12 msec ISI and 15 msec ISI was correlated
with sodium channel drug load (12 msec ISI r = 0.317,
P = 0.028; 15 msec ISI r = 0.328, P = 0.023). Note that
the difference in ICF between groups was not explained
by sodium channel drug load. No other correlations were
significant or close to significant.
Figure 1. Comparison of motor thresholds between groups shows
higher thresholds in poorly controlled epilepsy than moderately
controlled epilepsy, indicating reduced cortical excitability in poorly
controlled epilepsy. This difference was not explained by differences
in treatment or disease variables. Upper panel (A) shows resting
motor threshold (RMT), lower panel (B) shows active motor threshold
(AMT). Normal subjects shown in green, moderately controlled
subjects in blue, poorly controlled subjects in red. Comparisons
indicated with a bracket and * are significant at P < 0.05 Bonferroni
corrected, comparisons indicated with a bracket are significant at
P < 0.05 uncorrected.
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SICI and ICF: secondary analysis
We examined the generalized and focal epilepsy groups
separately using a threshold of P = 0.05 uncorrected;
therefore, these comparisons should be regarded as
exploratory trends. Group sizes were smaller than for
motor thresholds, especially the generalized group, and
these data were generally noisier, so effects were weaker.
In the generalized group, there were no differences
between moderately controlled, poorly controlled and
normal subjects for any ISI, although ICF at 15 msec ISI
showed a weak trend to be diminished in poorly con-
trolled patients vs. normal subjects (T = 2.350,
P = 0.059). In the focal group, we split the data into ipsi-
lateral and contralateral hemispheres. In the focal group,
poorly controlled patients differed from normal subjects
at 2 msec (reduced inhibition), 12 msec and 15 msec (re-
duced facilitation) in the ipsilateral hemisphere
(T = 2.636, P = 0.013; T = 4.799, P < 0.001; T = 5.471,
P < 0.001 respectively). Effects at the same ISIs were simi-
lar but weaker in the contralateral hemisphere (T = 2.278,
P = 0.029; T = 3.246, P = 0.002; T = 3.441, P = 0.001
respectively). In contrast, moderately controlled patients
showed fewer differences from normal subjects, with
reduction in ICF at 12 msec and 15 msec in the ipsilat-
eral hemisphere only (T = 2.569, P = 0.021; T = 3.980,
P < 0.001). Moreover, there was a greater reduction in
ICF at 15 msec ISI in the ipsilateral hemisphere in poorly
controlled than in moderately controlled patients
(T = 2.111, P = 0.047).
LICI: primary analysis
Comparing LICI between groups, although there was no
main effect of group, there was a significant interaction
Figure 2. Evolution of motor threshold with duration of epilepsy
differs between poorly controlled and moderately controlled epilepsy,
remaining stable over time in moderately controlled but increasing
over time in poorly controlled epilepsy. The correlation between
motor threshold and duration was not explained by differences in
treatment or disease variables. On the x-axis, subjects are allocated to
time bins based on epilepsy duration in years. Upper panel (A) shows
resting motor threshold (RMT), lower panel (B) shows active motor
threshold (AMT). Moderately controlled subjects shown in blue, poorly
controlled subjects in red. Comparisons marked with a bracket show
comparisons between moderately controlled and poorly controlled
that are significant P < 0.05 uncorrected. * indicates comparisons
between poorly controlled epilepsy and normal subjects that are
significant P < 0.05 Bonferroni corrected.
Figure 3. Comparison of SICI, ICF, and LICI between groups shows
reduced cortical excitability in poorly controlled epilepsy. Upper panel
(A) shows SICI and ICF, lower panel (B) shows LICI. On the x-axis is
shown the interstimulus interval in ms. Normal subjects shown in
green, moderately controlled subjects in blue, poorly controlled
subjects in red. Comparisons indicated with a bracket and * are
significant at P < 0.05 Bonferroni corrected, comparisons indicated
with a bracket are significant at P < 0.05 uncorrected. ICF,
intracortical facilitation; SICI, short-interval intracortical inhibition; LICI,
long-interval intracortical inhibition.
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between group and ISI (F = 3.205, P = 0.006, Figure 3).
Poorly controlled patients had inhibition at 50 ms ISI
whereas moderately controlled patients did not
(T = 2.582, P = 0.014); also, poorly controlled patients
tended to have inhibition at 200 ms ISI whereas normal
subjects did not (T = 2.199, P = 0.034); neither of these
comparisons survived correction for 12 multiple compar-
isons. The difference between well and poorly controlled
patients at 50 ms ISI was explored further, examining
potentially confounding covariates as described in the
Methods using a series of ANOVAs; in all instances,
effects remained significant at P < 0.05.
We explored the correlations between measures of LICI
and several covariates as described in the Methods. LICI
at 200 msec ISI was correlated with sodium channel drug
load (r = 0.311, P = 0.038). No other correlations were
significant or close to significant.
LICI: secondary analysis
We examined the generalized and focal epilepsy groups
separately using a threshold of P = 0.05 uncorrected;
therefore, these comparisons should be regarded as
exploratory trends. Group sizes were smaller than for
motor thresholds, especially the generalized group, and
these data were generally noisier, so effects were weaker.
In the generalized group, there were no differences
between moderately controlled, poorly controlled and
normal subjects for any LICI ISI. In the focal group, we
split the data into ipsilateral and contralateral hemi-
spheres. There were no differences between moderately
controlled and poorly controlled groups, although LICI at
50 msec showed a trend to being increased in ipsilateral
and contralateral hemispheres of poorly controlled
patients (T = 1.749, P = 0.097; T = 2.085, P = 0.063,
respectively). Furthermore, LICI at 200 msec ISI was
increased in moderately controlled and poorly controlled
patients compared to normals (T = 2.168, P = 0.040;
T = 2.114, P = 0.041).
CSP
CSP differed significantly between groups (F = 10.375,
P < 0.001). Both patient groups had significantly longer
CSP than normal subjects (moderately controlled vs.
normal T = 2.933, P = 0.005; poorly controlled vs. nor-
mal T = 4.006, P < 0.001) but there was no difference
between patient groups (T = 0.146, P = 0.885). There-
fore, although this measure differed between treated epi-
lepsy and normal subjects, it did not reveal any
differences between moderately controlled and poorly
controlled epilepsy, and was therefore not explored fur-
ther.
Discussion
In this study, we found that motor threshold was higher
in patients with poorly controlled epilepsy than moder-
ately controlled epilepsy, counterintuitively suggesting
that cortical excitability is lower in poorly controlled epi-
lepsy than moderately controlled. This difference in
motor threshold could not be explained by any differ-
ences between groups in age, age of onset of epilepsy, epi-
lepsy duration, or epilepsy type (focal or generalized).
Crucially, we found that this difference between moder-
ately controlled and poorly controlled epilepsy was not
explained by differences in AED treatment. We found
that motor threshold was higher in patients with poorly
controlled epilepsy than moderately controlled epilepsy in
generalized and focal epilepsy, although in the focal group
this effect was seen most strongly in the contralateral
hemisphere. Of particular note, we found that motor
threshold increased with duration of epilepsy, which
could not be explained by age, age of onset of epilepsy,
or AED treatment. This relationship between epilepsy
duration and motor threshold appeared to be confined to
the poorly controlled group, in which motor threshold
increased with duration. In contrast, motor threshold did
not increase with duration of epilepsy in the moderately
controlled group. At the shortest duration of epilepsy
(≤9 years duration), motor threshold in the poorly con-
trolled group did not differ significantly from motor
threshold in the moderately controlled group or the nor-
mal control group.
We found that ICF was diminished in poorly con-
trolled epilepsy but not in moderately controlled, again
counter-intuitively suggesting that cortical excitability is
lower in poorly controlled epilepsy than moderately con-
trolled. Furthermore, we found that the reduction of ICF
in poorly controlled patients, compared to moderately
controlled, was more easily detected in focal than general-
ized patients, although this reduction was not absent in
the generalized patients. Moreover, the reduction in ICF
was more marked in the ipsilateral hemisphere in focal
patients. In addition, we found that LICI at 50 msec and
200 msec was enhanced in poorly controlled epilepsy but
not in moderately controlled, once again counterintu-
itively suggesting that cortical excitability is lower in
poorly controlled epilepsy than moderately controlled.
This difference between groups was not explained by any
differences in epilepsy duration, epilepsy type (focal or
generalized), or drug treatment. The increase in LICI at
50 msec in poorly controlled patients was more easily
detected in the focal patients, although was not absent in
the generalized patients.
Our finding of increased motor threshold in AED-trea-
ted epilepsy patients is similar to previous findings in
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both focal6,10 and generalized epilepsy4,11. However, other
studies have found reduced thresholds in patients, but
these studies were typically in drug na€ıve new-onset
patients3,20,21. We propose that reduced cortical excitabil-
ity in longstanding poorly controlled epilepsy is a patho-
physiological feature of epilepsy, and not due to AED
treatment. Moreover, we propose that the increase in
motor threshold over time in poorly controlled epilepsy
is related to an as yet unknown pathophysiological factor
that evolves slowly over years, and is not due to AED
treatment.
It might appear difficult to reconcile our findings with
previous studies which found increased cortical excitabil-
ity in new-onset patients whose seizures did not come
under control with AEDs, compared to new-onset
patients who became seizure-free on AEDs8,22. In particu-
lar, we found that poorly controlled patients with long-
standing epilepsy had higher motor thresholds than mod-
erately controlled, whereas these previous studies found
that poorly controlled patients with new-onset epilepsy or
epilepsy for up to 3 years had lower motor thresholds
than seizure-free.8,9 Crucially, our data strongly suggest
that motor thresholds steadily increase over time in the
poorly controlled group, whereas thresholds remain stable
over time in the moderately controlled. Therefore, our
data would not rule out the possibility that motor thresh-
olds could be lower in poorly controlled than seizure-free
epilepsy in the early disease course.8,22 Our data suggest
that over time there is a marked drop in cortical
excitability in poorly controlled epilepsy, such that poorly
controlled patients have higher thresholds than moder-
ately controlled patients later in the disease course.
In this study, we did not attempt to examine the rela-
tionship between TMS measures and specific seizure
types. Although potentially of interest, such a study would
be challenging for several reasons, all of which are the
consequence of relying entirely on the patient’s ability to
provide a detailed history. Firstly, it is often difficult, on
the basis of the patient’s history, to distinguish between
focal seizures that involve or do not involve a disturbance
of consciousness (i.e. between seizures previously termed
simple and complex partial). Secondly, it is sometimes
difficult, on the basis of the patient’s history, to distin-
guish between a severe focal seizure with many motor fea-
tures and collapse versus a bilateral convulsive seizure.
Thirdly, and crucially, in order to determine whether the
occurrence of specific seizure types determines changes in
TMS measures over a very long period of time, we would
need a completely accurate record of all seizure types
occurring over a period of up to several decades, and for
this record to be sufficiently detailed to include seizures
that occurred rarely (e.g., a bilateral convulsive seizure
occurring decades ago in a patient with temporal lobe
epilepsy) or seizures that are often missed (eg. absences in
patients with juvenile myoclonic epilepsy); such an accu-
rate and complete record is very rarely available.
At this point, we cannot provide a detailed understand-
ing of exactly which mechanistic features of the epileptic
brain TMS is able to detect. Although simplistic descrip-
tions of TMS measurements often use terms such as ‘in-
hibition’ and ‘excitation’ in a manner suggesting that
underlying mechanisms of TMS effects are understood,
the detailed underlying mechanisms are not known. There
are some informative models explaining how TMS stimuli
may be converted to a motor output and how that output
may be modulated by drugs and by paired-pulse stimula-
tion protocols.23,24 The models have in common that
TMS motor output is determined by the membrane
potentials of neurons having input to cortical layer 5
pyramidal neurons, the nature of the input (inhibitory or
excitatory), the number of inputs (synapses), and the
membrane potential of the pyramidal neurons. Although
more detailed understanding is missing at the current
time, it is plausible that this set of neurons and connec-
tions is highly relevant to the epileptic process. Although
none of our patients had seizure onset in a focal region
of the motor cortex, finding physiological abnormalities
in a brain region remote from putative seizure onset
zones is increasingly accepted as part of the network
hypothesis of epilepsy.25,26
Although it is a widely used method, using peripheral
EMG as an index of cortical excitability measured with
TMS is somewhat indirect; increasingly, EEG is being col-
lected concurrently with TMS in order to assess cortical
excitability from a more direct readout.27–29 In a study of
focal-onset patients, it was shown that abnormal EEG
phenomena could be induced by focal TMS stimulation
during periods of otherwise normal EEG, whereas no
such abnormal phenomena could be induced in healthy
normal subjects, suggesting that enhanced excitability of
the epileptic brain can be revealed by TMS-EEG.27 A sub-
sequent study in IGE revealed similarly that epileptiform
discharges could be induced by TMS, and also that TMS
could unmask covert states of hyperexcitability in which
discharges were more likely to occur.28 Furthermore,
TMS-EEG may allow these abnormal responses to be
anatomically mapped into the underlying epileptic brain
network.29 A future study using TMS-EEG to examine
the effects of epilepsy severity and duration may therefore
cast light on the underlying pathophysiological mecha-
nisms.
An important question, not addressed by this study, is
whether the increase in motor threshold over time in the
poorly controlled group is due to progressive brain atro-
phy affecting the poorly controlled more than the moder-
ately controlled group. It is well established that an
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increased distance between skull and motor cortex is
associated with an elevated motor threshold, with each
millimetre of increased distance increasing the RMT by
2–4%.30–32 To account for the observations made here,
the distance between skull and motor cortex in the poorly
controlled group would need to be approximately
4–8 mm greater than in the well-controlled group. We do
not have imaging data to address this question, but this
additional degree of atrophy seems substantial. Moreover,
although some studies show an association between atro-
phy and number of seizures33,34, other studies have shown
similar atrophy in well-controlled patients35,36. A cross-
sectional study suggests that atrophy progresses more
quickly in patients with a duration of epilepsy
>14 years.37 Nevertheless, to conclusively determine
whether the differences in motor threshold observed in
this study are due to differences in cortical excitability
specifically, these measures could be obtained in patients
with neuroimaging so that any group differences in scalp-
cortex distance and/or cortical thickness can be accounted
for.
It may seem surprising that similar effects could be
observed across a very wide range of epilepsy syn-
dromes and AED treatments. However, at least three
arguments support the proposition that there are unify-
ing mechanistic features across the range of epilepsies
that could allow similar effects across epilepsy syn-
dromes and AEDs. Firstly, although numerous genetic
and acquired abnormalities are associated with seizures
and epilepsy, nonetheless, there may be unifying mecha-
nisms at the macroscale that are common to different
microscale causes. Theoretical modelling work based on
seizures from several epilepsy models suggests that,
across the range of epilepsy types, a small set of system
parameters are responsible for seizure onset, evolution,
offset and recurrence.38 Secondly, evidence suggests that
both focal and generalized seizures have their onset in
localized microcircuits,39 which may be epileptogenic
because of specific connectivity patterns or motifs that
are similar across different types of epilepsy.40 Thirdly,
the existence of broad-spectrum AEDs suggests that
similar mechanisms prevent seizure onset across a wide
range of epilepsy syndromes.41 Therefore, we argue that
there are multiple underlying microscale mechanisms of
epilepsy, but at the macroscale there is a limited set of
rules governing the dynamics of seizure onset and off-
set, and a limited set of mechanisms to stabilize seizure
networks.
We believe the study described here, and previous stud-
ies8,9, have identified a feature of the epileptic brain, simi-
lar across syndromes, that evolves very slowly over a
timescale of years, and differs fundamentally between
well-controlled and poorly controlled epilepsy.
Acknowledgements
The study was supported by a PhD studentship from Epi-
lepsy Action held by A.P.; a UK Medical Research Coun-
cil (MRC) Clinical Research Training Fellowship held by
F.A.C.; and a Programme Grant from MRC held by
M.P.R. (MR/K013998/1). M.P.R. is supported in part by
the National Institute for Health Research (NIHR)
Biomedical Research Centre in Mental Health at the
South London and Maudsley NHS Foundation Trust and
by the UK Engineering and Physical Sciences Research
Council (EPSRC) Centre for Predictive Modelling in
Healthcare at the University of Exeter (EP/N014391/1).
Author Contributions
A.D.P. contributed to conception and design of the study,
acquisition and analysis of data, drafting a significant por-
tion of the manuscript or figures. F.A.C. also contributed
to conception and design of the study, acquisition and
analysis of data. C.T. contributed to acquisition and anal-
ysis of data. B.C. also helped in the acquisition and analy-
sis of data.L.F: conception and design of the study,
acquisition of data. M.P.R contributed to conception and
design of the study, acquisition and analysis of data,
drafting a significant portion of the manuscript or figures.
Conflict of Interest
The authors report no conflicts of interest.
References
1. Kimiskidis VK, Valentin A, Kalviainen R. Transcranial
magnetic stimulation for the diagnosis and treatment of
epilepsy. Curr Opin Neurol 2014;27:236–241.
2. Tataroglu C, Ozkiziltan S, Baklan B. Motor cortical
thresholds and cortical silent periods in epilepsy. Seizure
2004;13:481–485.
3. Manganotti P, Bongiovanni LG, Zanette G, et al. Early and
late intracortical inhibition in juvenile myoclonic epilepsy.
Epilepsia 2000;41:1129–1138.
4. Akgun Y, Soysal A, Atakli D, et al. Cortical excitability in
juvenile myoclonic epileptic patients and their
asymptomatic siblings: a transcranial magnetic stimulation
study. Seizure 2009;18:387–391.
5. Cantello R, Civardi C, Cavalli A, et al. Cortical excitability
in cryptogenic localization-related epilepsy: interictal
transcranial magnetic stimulation studies. Epilepsia
2000;41:694–704.
6. Cicinelli P, Mattia D, Spanedda F, et al. Transcranial
magnetic stimulation reveals an interhemispheric
asymmetry of cortical inhibition in focal epilepsy.
NeuroReport 2000;11:701–707.
ª 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 95
A.D. Pawley et al. TMS in Chronic Epilepsy
7. Ziemann U, Lonnecker S, Steinhoff BJ, et al. Effects of
antiepileptic drugs on motor cortex excitability in humans:
a transcranial magnetic stimulation study. Ann Neurol
1996;40:367–378.
8. Badawy RA, Macdonell RA, Berkovic SF, et al. Predicting
seizure control: cortical excitability and antiepileptic
medication. Ann Neurol 2010;67:64–73.
9. Badawy RA, Jackson GD, Berkovic SF, et al. Cortical
excitability and refractory epilepsy: a three-year
longitudinal transcranial magnetic stimulation study. Int J
Neural Syst 2013;23:1250030.
10. Hamer HM, Reis J, Mueller HH, et al. Motor cortex
excitability in focal epilepsies not including the primary
motor area–a tms study. Brain 2005;128:811–818.
11. Caramia MD, Gigli G, Iani C, et al. Distinguishing forms
of generalized epilepsy using magnetic brain stimulation.
Electroencephalogr Clin Neurophysiol 1996;98:14–19.
12. Moran NF, Poole K, Bell G, et al. Epilepsy in the united
kingdom: seizure frequency and severity, anti-epileptic
drug utilization and impact on life in 1652 people with
epilepsy. Seizure 2004;13:425–433.
13. Hoppe C, Poepel A, Elger CE. Epilepsy: accuracy of
patient seizure counts. Arch Neurol 2007;64:1595–1599.
14. Chowdhury FA, Pawley AD, Ceronie B, et al. Motor evoked
potential polyphasia: a novel endophenotype of idiopathic
generalized epilepsy. Neurology 2015;84:1301–1307.
15. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive
electrical and magnetic stimulation of the brain, spinal
cord and roots: basic principles and procedures for routine
clinical application. Report of an ifcn committee.
Electroencephalogr Clin Neurophysiol 1994;91:79–92.
16. King NK, Kuppuswamy A, Strutton PH, et al. Estimation
of cortical silent period following transcranial magnetic
stimulation using a computerised cumulative sum method.
J Neurosci Methods 2006;150:96–104.
17. Ziemann U, Reis J, Schwenkreis P, et al. Tms and drugs
revisited 2014. Clin Neurophysiol 2015;126:1847–1868.
18. Guidelines for atc classification and ddd assignment. 2015.
Oslo: WHO Collaborating Centre for Drug Statistics
Methodology, 2015.
19. White HS, Smith MD, Wilcox KS. Mechanisms of action
of antiepileptic drugs. Int Rev Neurobiol 2007;81:85–110.
20. Kazis DA, Kimiskidis VK, Papagiannopoulos S, et al. The
effect of valproate on silent period and corticomotor
excitability. Epileptic Disord 2006;8:136–142.
21. Reutens DC, Berkovic SF. Increased cortical excitability in
generalised epilepsy demonstrated with transcranial
magnetic stimulation. Lancet 1992;339:362–363.
22. Badawy RA, Vogrin SJ, Lai A, et al. The cortical
excitability profile of temporal lobe epilepsy. Epilepsia
2013;54:1942–1949.
23. Esser SK, Hill SL, Tononi G. Modeling the effects of
transcranial magnetic stimulation on cortical circuits. J
Neurophysiol 2005;94:622–639.
24. Rusu CV, Murakami M, Ziemann U, et al. A model of
tms-induced i-waves in motor cortex. Brain Stimul
2014;7:401–414.
25. Richardson MP. Large scale brain models of epilepsy:
dynamics meets connectomics. J Neurol Neurosurg
Psychiatry 2012;83:1238–1248.
26. Richardson M. Current themes in neuroimaging of
epilepsy: brain networks, dynamic phenomena, and clinical
relevance. Clin Neurophysiol 2010;121:1153–1175.
27. Valentin A, Arunachalam R, Mesquita-Rodrigues A, et al.
Late EEG responses triggered by transcranial magnetic
stimulation (TMS) in the evaluation of focal epilepsy.
Epilepsia 2008;49:470–480.
28. Kimiskidis VK, Koutlis C, Tsimpiris A, et al. Transcranial
Magnetic Stimulation combined with EEG reveals covert
states of elevated excitability in the human epileptic brain.
Int J Neural Syst 2015;25:1550018.
29. Shafi MM, Vernet M, Klooster D, et al. Physiological
consequences of abnormal connectivity in a developmental
epilepsy. Ann Neurol 2015;77:487–503.
30. Stokes MG, Chambers CD, Gould IC, et al. Simple metric
for scaling motor threshold based on scalp-cortex distance:
application to studies using transcranial magnetic
stimulation. J Neurophysiol 2005;94:4520–4527.
31. McConnell KA, Nahas Z, Shastri A, et al. The transcranial
magnetic stimulation motor threshold depends on the
distance from coil to underlying cortex: a replication in
healthy adults comparing two methods of assessing the
distance to cortex. Biol Psychiatry 2001;49:454–459.
32. Kozel FA, Nahas Z, deBrux C, et al. How coil-cortex
distance relates to age, motor threshold, and antidepressant
response to repetitive transcranial magnetic stimulation. J
Neuropsychiatry Clin Neurosci 2000;12:376–384.
33. Coan AC, Appenzeller S, Bonilha L, et al. Seizure
frequency and lateralization affect progression of atrophy
in temporal lobe epilepsy. Neurology 2009;73:834–842.
34. Coan AC, Campos BM, Yasuda CL, et al. Frequent
seizures are associated with a network of gray matter
atrophy in temporal lobe epilepsy with or without
hippocampal sclerosis. PLoS ONE 2014;9:e85843.
35. Bilevicius E, Yasuda CL, Silva MS, et al. Antiepileptic drug
response in temporal lobe epilepsy: a clinical and mri
morphometry study. Neurology 2010;75:1695–1701.
36. Alvim MK, Coan AC, Campos BM, et al. Progression of
gray matter atrophy in seizure-free patients with temporal
lobe epilepsy. Epilepsia 2016;57:621–629.
37. Bernhardt BC, Rozen DA, Worsley KJ, et al. Thalamo-
cortical network pathology in idiopathic generalized
epilepsy: Insights from MRI-based morphometric
correlation analysis. NeuroImage 2009;46:373–381.
38. Jirsa VK, Stacey WC, Quilichini PP, et al. On the nature
of seizure dynamics. Brain 2014;137:2210–2230.
39. Meeren HK, Pijn JP, Van Luijtelaar EL, et al. Cortical
focus drives widespread corticothalamic networks during
96 ª 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
TMS in Chronic Epilepsy A.D. Pawley et al.
spontaneous absence seizures in rats. J Neurosci
2002;22:1480–1495.
40. Paz JT, Huguenard JR. Microcircuits and their interactions
in epilepsy: is the focus out of focus? Nat Neurosci
2015;18:351–359.
41. Bourgeois BF. Broader is better: the ranks of broad-
spectrum antiepileptic drugs are growing. Neurology
2007;69:1734–1736.
Supporting Information
Additional Supporting Information may be found online
in the supporting information tab for this article:
Figure S1: SICI and ICF at ISIs of 2, 3, 12 and 15 msec.
Figure S2: LICI at ISIs of 50, 100, 200 and 250 msec.
ª 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 97
A.D. Pawley et al. TMS in Chronic Epilepsy
